Email not displaying correctly? View it in your browser
Forward to a colleague | Sign up to BNF eNews
BNF BNF for Children Medicines Complete
July 2017 Share this issue Facebook LinkedIn Twitter
 
I Welcome
Welcome to the July BNF eNewsletter.
Three new drug monographs have been added to the BNF in the last month, including - emtricitabine with tenofovir alafenamide, elvitegravir with cobicistat, emtricitabine and tenofovir alafenamide, and emtricitabine with rilpivirine and tenofovir alafenamide. We have included dose changes for fenofibrate in renal impairment.

This issue highlights new guidance on pre-exposure prophylaxis for HIV infection, low back pain and sciatica, as well as updated guidance on constipation, interactions with contraceptives, diabetes, prescribing in renal impairment and influenza vaccination for winter 2017-2018. We also have MHRA advice on finasteride: rare reports of depression and suicidal thoughts.

This month take a look at our BNF case study on Crohn's disease and the treatment options available.
Kind regards,
BNF Team
I In this issue
Forthcoming changes for BNF and MedicinesComplete More > 
Significant changes More > 
News More > 
How to purchase BNF More > 
Price reminder More > 
Drug safety update More > 
Feedback More > 
I Forthcoming changes for BNF and MedicinesComplete
As users of BNF Publications we would like to inform you of some important developments taking place with BNF and BNFC over the coming months. We will be sending detailed information about each of these areas separately, so keep an eye out for those that are most relevant to your practice.
NEW BNF DRUG INTERACTIONS
We've listened to your feedback around ways that we could improve BNF interactions and, as a result, we have redeveloped the interactions content. The improvements also reflect changes in how interactions are studied and the regulatory framework that surrounds this.

In the coming months we will introduce the following content improvements:

Increased coverage and a greater focus on the clinical relevance of the interactions
A consistent style and terminology across all BNF Publications
A new grading system for both the severity of the interaction and the evidence to support it.

If you would like more information on the coming changes please visit the BNF website.
BNF LEGACY RETIREMENT
BNF content moved to a digital-first structure in 2015 to allow the development of bespoke digital products, such as the recently released new BNF app. On MedicinesComplete this provided users with a drug and treatment-centric view of BNF content.

To help users become familiar with the change, we have ensured users had access to both legacy and current formats. A high adoption rate of the current structure, the withdrawal of the legacy content from NICE Evidence in June 2017, and the forthcoming retirement of the NICE app means that we are now retiring this version.

MedicinesComplete will retire legacy content in Oct 2017 and replace this with the legacy hierarchy for any users who wish to view the previous chapter structure.
MedicinesComplete DEVELOPMENT AND REGISTRATION PROCESS
As part of our continued investment in MedicinesComplete we are working behind the scenes in developing new features and functionality for our users. In the coming months, we will be introducing an updated registration process providing NHS users access to BNF and BNF for Children on MedicinesComplete.

Thank you for taking the time to read this information and in the coming months we will be updating you with further information on these developments as well as bringing news and information about BNF Publications.
I Significant
changes
This month's changes to the clinical content of these publications are described in two parts:

BNF and BNFC update should be read by all users
BNF update should be read by all users of the BNF
BNFC update should be read by all users of the BNFC
BNF 73 - BNFC 2016-2017
BNF Update
Breast cancer: updated guidance on chemoprevention of familial breast cancer
For further information, see breast cancer.
HIV infection: new guidance pre-exposure prophylaxis
For further information, see HIV infection.
Prescribing in renal impairment: updated guidance
For further information, see prescribing in renal impairment.
Finasteride: rare reports of depression and suicidal thoughts (MHRA/CHM advice)
For further information, see finasteride.
Other changes
To review other changes in the BNF, click on changes.
BNF for Children Update
Eltrombopag: new drug monograph
For further information, see eltrombopag.
Other changes
To review other changes in BNF for Children, click on changes.
BNF BNF for Children Update
Elvitegravir with cobicistat, emtricitabine and tenofovir alafenamide: new drug monograph
For further information, see elvitegravir with cobicistat, emtricitabine and tenofovir alafenamide.
Contraceptives, interactions: updated guidance
For further information, see contraceptives, interactions.
Diabetes: updated guidance on management
For further information, see diabetes.
Vaccines: updated guidance on influenza vaccination for winter 2017-2018
For further information, see vaccines.
Fenofibrate: dose in renal impairment
For further information, see fenofibrate.
Other changes
To review other changes, click on changes.
I News
Reminder - help from CPPE with BNF 73
An interactive PDF e-learning programme from the Centre for Pharmacy Postgraduate Education (CPPE) will help you familiarise yourself with recommendations in BNF 73. It comprises 10 practical case studies, and can be accessed here.
BNF 73
I How to purchase BNF
Purchase Print copies
Purchase print copies
To order the March 2017 edition, visit the Pharmaceutical Press website.
More
Purchase a print subscription
Purchase a print subscription and save money
A print subscription is the best way to ensure access to the latest copy of BNF as soon as it publishes.
More
BNF online
BNF online
Outside the UK, content is available via a subscription to MedicinesComplete.
Email us
BNF eBook
BNF eBook
BNF is also available as a PDF eBook.
More
I Monthly price update reminder
Prices of all branded medicinal products in the BNF and BNFC are now updated monthly. Prices of generic preparations of medicinal products are updated every 2-4 months, to coincide with print editions of BNF and BNF for Children. The BNF team keep price information up to date using data sourced from the NHS dictionary of medicines and devices (dm+d).
Drug Safety Update
Drug Safety Update is a monthly newsletter from
the MHRA and Commission on Human Medicine.
Please follow this link to review this month's Drug Safety Update.
I Feedback on our eNewsletter
Please let us know if there are any issues that you'd like us to address in our eNewsletters. We welcome your feedback. If you have any comments or suggestions, please let us know at marketing@rpharms.com.
Subscribe to this eNewsletter here
I Related Products
Medicines Complete BNF Pharmaceutical Press
BNF
Copyright © 2017 BMJ Publishing Group Ltd and the Royal Pharmaceutical Society of Great Britain. All rights reserved. Terms of use.
BNF for Children
Copyright © 2017 BMJ Publishing Group Ltd, the Royal Pharmaceutical Society of Great Britain and RCPCH Publications. All rights reserved. Terms of use.
If you do not wish to receive such mailings in the future please click here to unsubscribe.
Pharmaceutical Press, 66-68 East Smithfield, London, E1W 1AW, United Kingdom.